Consumer gut-microbiome tests can produce sharply different results from the same stool sample, raising questions about their reliability and clinical value. NirvanaBiome reported 133 microorganism species in one sample and rated the result “excellent,” while Viome identified 61 active types and recommended dietary changes and supplements. Scientists say differences in sampling, laboratory methods, genetic analysis and definitions of a “healthy” microbiome make the findings difficult to interpret or trust.
Revealed: How this common gut microbe protects against heart disease
NirvanaBiome, a company in Germantown, Maryland, analyzed one stool sample and reported that 133 species of microorganisms were living in the sample. It described the collection as “excellent,” based on the overall diversity of the gut microbes and the levels of specific beneficial and undesirable species.
A second analysis delivered a less encouraging assessment. Viome, based in Bellevue, Washington, identified only 61 types of microorganisms active in the gut, suggesting that some microbes might not be functioning optimally. The company recommended dietary changes and customized supplements.
The conflicting results were perplexing, but microbiologist Rob Knight, director of the Center for Microbiome Innovation at the University of California, San Diego, says this reaction is common. When scientists tested several microbiome kits side by side in a formal study, the results varied widely. Such differences make it difficult to understand or trust the findings from any particular provider, says Diane Hoffman, director of the Law and Medicine Program at the University of Maryland in Baltimore and a co-author of one of the studies.
The companies defend their products. “Of course there is variation,” says Kelly Moffat, chief operations officer at Cambio, a Germantown company that performs the laboratory work and genetic sequencing for NirvanaBiome. “This is a complex test, so there has to be one.”
Momo Vujicic, chief scientific officer at the Biome Research Institute in Bothwell, Washington, says he was not surprised by the level of variation in the formal study. Laboratories use different methods to extract, sequence and analyze microbial genetic material. Viome, for example, sequences RNA rather than DNA. This can show not only which genes are present, but also which genes are active in microorganisms. Vujicic argues that activity is more relevant to human health. Although every method has biases, he says consumers who use the same provider should obtain results that can be compared over time.
Interest in microbiome testing is growing. “There’s a lot of public enthusiasm and excitement about the microbiome,” Knight says. Some customers are curious about the microorganisms living inside their bodies and their possible effects on health. Others have conditions such as irritable bowel syndrome and hope their gut microbes will reveal an underlying cause or suggest a route to better health.
People can order tests and follow the recommendations without consulting a medical professional, although some take their results to doctors. “When I see someone come in for a microbiome test, I groan,” says Fergus Shanahan, a gastroenterologist and immunologist at University College Cork in Ireland who has spent much of his career studying the microbiome.
For people with gut-health problems, consumer microbiome profiles are generally not specific enough to be useful, Shanahan says. If someone is concerned about an infection such as Clostridioides difficile, it is easier to test for known pathogens than to assess the entire microbial community.

Interesting connections between gut microbes and the brain
Microbiologists and gastroenterologists who spoke to Nature generally agreed that microbiome testing could eventually help reflect and promote health. But many said the science is not yet mature enough to support widespread consumer testing. They said current tests have limited clinical value and might not be cost-effective, given prices of approximately US$100–300.
Experts also warn that acting on advice that has not come from a clinician could lead people to adopt unnecessarily restrictive diets or delay appropriate medical evaluation. Critics say consumer microbiome testing needs greater regulatory scrutiny and oversight.
“This is an industry out of control,” says genomicist Jack Lovell, director of the Center for Advanced Microbiome Research and Innovation at the University of Maryland School of Medicine in Baltimore and a co-author of one study that tested multiple providers. There are no standards governing testing methods, he says.
“I think the jury is out on exactly what we can actually do today based on this data,” Moffat says. However, she adds that microbiome profiles combined with other tests, such as gut metabolomics, could provide useful health information.
An attractive proposal
The gut microbiome has been linked to many aspects of health. Studies have associated the trillions of microorganisms in the gastrointestinal tract with immune function, metabolism, skin diseases and mental health. The idea of measuring the population and activity of these microbes to monitor and improve gut health in a personalized way is appealing. Viome’s website, for example, promises: “No more trial and error…follow a plan created precisely for you.”
Companies can identify microbial species and then infer what those microbes might be doing, such as producing metabolites or promoting inflammation. But even a basic microbiome test can be expensive, says Alessandra Cervino, research director at PiLeJe, a science-based food-supplement company in Paris. Cervino says her microbiome-testing company, Luxia Scientific, closed in 2024 for financial reasons.

Some microbiome-testing companies recommend fermented foods such as kombucha for gut health.Credit: Deb Lindsey Washington Post via Getty
Many testing companies offer lifestyle and nutritional advice or sell supplements. Viome analyzed several functions attributed to gut microbes, including digestive efficiency, gas production and serotonin production. It then provided a detailed meal plan that recommended eating fewer broccoli servings and more pecans, along with precision supplements and probiotics costing more than $150 per month.
Although changing the composition of the gut microbiome is difficult, changes in diet—and even aging—can alter microbial activity, Vujicic says. Viome recommends retesting every four to six months to confirm changes and update a plan.
Vujicic points to Viome’s 19 peer-reviewed publications as evidence of the company’s scientific rigor (go.nature.com/4actdhq). One consumer analysis of how gut bacteria influence a person’s response to glucose in different foods was supported in part by published data from 550 people in the United States. The participants ate more than 30,000 meals in total while wearing blood-sugar monitors.1 Vujicic says the company also validated the results in an additional cohort in Japan, but those data have not been made public.
Tim Spector, a physician and scientist at King’s College London and co-founder of the London-based company ZOE, says microbiome tests are not all equivalent. ZOE offers microbiome testing and supplements in addition to the gut-health app used in this assessment. Spector says ZOE’s products are supported by research involving thousands of people. “There’s definitely some not-so-good players that give this field a bad name,” he says. “It’s not easy to do this well.”
Testing the tests
Microbiome tests can be performed in several ways, and at least two studies have shown that companies’ different approaches produce different results. Scientists at the National Institute of Standards and Technology (NIST) in Gaithersburg, Maryland, sent homogenized stool samples from one person to seven companies.2
NIST’s mission includes developing and applying measurement standards. The experiment was intended to help researchers understand the range of testing options available, says study author Stephanie Servetas, a NIST microbiologist based in Sheridan, Wyoming. The researchers did not name the companies in their report because they wanted to compare tests rather than assess the perceived accuracy of individual providers.
The results were striking. “Companies produce surprisingly different results,” says co-author Scott Jackson, a molecular geneticist who previously directed the NIST Microbiology Program and is now a consultant in St. Michael’s, Maryland. “They couldn’t even agree on what was healthy and what was unhealthy,” he says.
The reports identified between 34 and 906 microbial genera. Only three genera appeared in all of them. Although every test used material from the same person, the results differed between companies almost as much as results typically differ between people.
A team in Europe and Canada found similar results after anonymizing a homogenized stool sample from one person and sending it to six companies. Three companies rated the microbial diversity as “excellent” or “good,” two called it “average,” and one described it as “a disadvantage.”3
The results were highly variable, and at least some tests must lack validation and standardization, says co-author Celine Druart, executive director of the Brussels-based Pharmabiotic Research Institute (PRI), a nonprofit organization focused on regulating microbiome innovation. “It’s very difficult to draw conclusions,” she says.

How gut bacteria can promote cancer treatment
Jack Gilbert, director of the Center for Microbiome and Metagenomics at the University of California, San Diego, says the discrepancy is not surprising. Variation begins with sample collection. A person might scoop a small amount of feces into a tube, use a coring device or wipe a sampler across used toilet paper. The sample might be shipped untreated or with a preservative, as both the Viome and NirvanaBiome kits requested. Each choice can affect the balance of microbes collected and the organisms that survive to be sequenced.
Laboratory extraction methods create another source of variation, Servetas says. Gentler protocols favor microorganisms that are easy to open, whereas harsher methods can capture a greater proportion of species with more robust cell structures.
After sequencing, laboratories also use different bioinformatics pipelines, Knight says. Their analyses may differ in how many gene sequences are required to conclude that a microorganism is present and which reference sequences and microbial lists are used. “If you do the computational analysis the way you like, all bets are off,” Knight says.
Some companies support the development of testing standards. “We’re very supportive of really having standards here,” says Kimberly Skum, chief scientific officer at Tiny Health in Austin, Texas, which offers gut- and vaginal-microbiome testing.
Establishing standards is difficult in part because there is no known “truth” for a natural microbial sample. Blood-sugar laboratories can compare their results with known values from standardized samples. The complexity of the microbiome does not allow for such a straightforward comparison.
NIST used samples mixed from multiple human donors to develop standards.4 Tiny Health is experimenting with synthetic reference materials made from individual microbial species rather than feces.5 Neither type of standard is exactly equivalent to an individual person’s microbiome.
What is a healthy sample?
Even if laboratories could fully characterize the microbiome, interpretation would remain difficult. Unlike blood glucose, which has established ranges associated with health, there is no single definition of a healthy microbiome. Each person’s microbial community is unique, much like a fingerprint.
According to Shanahan, there are countless ways for a microbiome to be healthy and countless ways for it to be unhealthy. The boundary between the two is not clearly defined.

How gut microbes cause brain damage
Testing companies therefore need to compare customers’ microbiomes with some form of health standard, but those standards also differ. They might be based on previous customers or large public databases. Microbiomes vary widely according to factors including ethnicity, sex, age, recent antibiotic use and whether a person was born by caesarean section.
Source: www.nature.com












